Announced Wed, 30 Sept, 2026 · 14:36 IST

40th AGM: All 5 resolutions passed with 100% approval

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.4%Reaction day
₹6.15
prior close
₹6.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-2.2% vs market
Pharmaceuticals peers, median of 172sector-0.9%-1.5% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.4-0.3-2.2-0.9-1.5
Next day
-2.4-1.5-0.9-1.6-0.8
2d
-7.8-1.5-6.3-2.5-5.3
3d
-8.1-0.2-7.9-1.3-6.9
4d
-2.6-0.5-2.1-1.8-0.8
5d
-7.5-3.2-4.2-3.4-4.0
1w
-5.7-2.2-3.5-4.3-1.4
15d
-17.4-9.5-7.9-9.1-8.3
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Decipher Labs held its 40th AGM on 30 Sep 2026 via video conferencing. All 5 resolutions passed unanimously with 100% votes in favour and none against. Items included: adoption of FY26 audited financial statements, reappointment of Mr Sushant Mohan Lal as director, appointment of M/s Ramanatham and Rao as statutory auditors, appointment of Mr Bhupendralal Waghray as independent director, and approval of material related party transactions with Saya Healthcare. Only about 2.70% of outstanding shares participated in voting, indicating very low shareholder turnout.

Likely market impact

Routine outcome - all items approved. Low 2.70% voting turnout signals limited shareholder engagement. Related party deal with Saya Healthcare needs monitoring.